Skip to main content

Somatropin

Also known as: Recombinant human growth hormone, rhGH, HGH, Genotropin, Norditropin, Humatrope

Classification

Hormone

Regulatory Status

FDA-approved prescription biologic/drug (product-specific somatropin labels)

Sources

4

Review

n/a

Overview

Somatropin is recombinant human growth hormone (191 amino acids) with the same sequence as pituitary GH; it acts via GH receptors and IGF-1 pathways to promote growth and metabolic effects as labeled.

Evidence and limitations

Human/preclinical evidence breakdown is not available in this record.

Pathways

gh-igf1-axisgrowth hormone receptor agonismIGF-1 pathway activationGHR

Benefits

FDA-approved somatropin products (e.g., Genotropin) are labeled for multiple pediatric growth disorders and for adult growth hormone deficiency as specified in product labeling. Educational reference only.

Interactions & cautions

glucocorticoids — May inhibit growth-promoting effects. (review)

insulin or other antidiabetic agents — Antidiabetic regimen may need adjustment. (review)

These are observational flags for review, not individualized instructions.

Sources

Educational reference only — not medical advice.

What people report (anecdote)

CLINICAL DATA (from trials)

Adverse events:

None recorded in our sources.

Effects measured:

Human trials: none found.

ANECDOTE

What people report: anecdote, not evidence

Loading…

Submit a claim you saw
Somatropin: what the evidence actually says | BioStack